CURATIS N AG Asset Resilience Ratio

Latest as of June 2025: 3.75%

CURATIS N AG asset resilience ratio. CURATIS N AG (CURN) has an Asset Resilience Ratio of 3.75% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read total liabilities of CURATIS N AG for a breakdown of total debt and financial obligations.

Liquid Assets

CHF2.04 Million
≈ $2.59 Million USD Cash + Short-term Investments

Total Assets

CHF54.52 Million
≈ $68.93 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio of CURATIS N AG (2022–2024)

Asset resilience ratio of CURATIS N AG from 2022 to 2024. This chart shows how CURATIS N AG's Asset Resilience Ratio has changed over time. See CURN free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Liquid Assets Composition Over Time

This chart breaks down CURATIS N AG's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see CURN total assets.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CHF2.04 Million 3.75%
Short-term Investments CHF0.00 0%
Total Liquid Assets CHF2.04 Million 3.75%

Asset Resilience Insights

  • Limited Liquidity: CURATIS N AG maintains only 3.75% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company primarily holds liquidity in cash and equivalents rather than short-term investments.

CURATIS N AG Industry Peers by Asset Resilience Ratio

Compare CURATIS N AG's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Takeda Pharmaceutical Company Limited
F:TKDA
Drug Manufacturers - Specialty & Generic 0.69%
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK
Drug Manufacturers - Specialty & Generic 4.94%
Curaleaf Holdings Inc.
TO:CURA
Drug Manufacturers - Specialty & Generic 3.73%
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
Drug Manufacturers - Specialty & Generic 5.90%
Zhejiang Medicine Co Ltd
SHG:600216
Drug Manufacturers - Specialty & Generic 1.85%
Hunan Warrant Pharmaceutical Co. Ltd. A
SHG:688799
Drug Manufacturers - Specialty & Generic 0.40%
Dezhan HealthCare Co Ltd
SHE:000813
Drug Manufacturers - Specialty & Generic 0.09%
Chongqing Pharscin Pharmaceutical Co Ltd
SHE:002907
Drug Manufacturers - Specialty & Generic 14.54%

CURATIS N AG Asset Resilience Ratio by Year (2022–2024)

CURATIS N AG asset resilience ratio by year from 2022 to 2024. The table below shows the annual Asset Resilience Ratio data for CURATIS N AG.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 5.43% CHF3.01 Million
≈ $3.81 Million
CHF55.54 Million
≈ $70.21 Million
+5.42pp
2022-12-31 0.01% CHF1.00K
≈ $1.26K
CHF14.05 Million
≈ $17.76 Million
--
pp = percentage points

About CURATIS N AG

SW:CURN Switzerland Drug Manufacturers - Specialty & Generic
Market Cap
$113.33 Million
CHF89.64 Million CHF
Market Cap Rank
#19485 Global
#190 in Switzerland
Share Price
CHF17.40
Change (1 day)
+2.96%
52-Week Range
CHF11.30 - CHF26.00
All Time High
CHF891.52
About

Curatis Holding AG engages in the acquisition, development, and commercialization of medicines for the prevention, diagnosis, and treatment of rare and specialty care diseases. It offers its products in the areas of fentanyl, breakthrough pain, antiplatelet, metastatic hormone receptor-positive breast cancer, anti-arrhythmic, nasal oil, wilson's disease, cyanide poisoning, digoxin toxicity, antih… Read more